Collegium Pharmaceutical (FRA:354) Institutional Ownership: 89.56% (As of Aug. 06, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:354 Collegium Pharmaceutical Inc FRA:354
78 GF Score
Price €30.60
GF Value €36.94
! 3 Warning Signs
View Full Analysis

What is Collegium Pharmaceutical Institutional Ownership?

Collegium Pharmaceutical FRA:354 +0.66% 78 Institutional Ownership is 89.56% as of Aug. 06, 2026. GuruFocus rates FRA:354 with a GF Score™ of 78/100 and a GF Value™ of €36.94. The stock has 3 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Collegium Pharmaceutical's institutional ownership is 89.56%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Collegium Pharmaceutical's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Collegium Pharmaceutical's Float Percentage Of Total Shares Outstanding is 83.66%.

Collegium Pharmaceutical Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Collegium Pharmaceutical's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Collegium Pharmaceutical Institutional Ownership Chart

Collegium Pharmaceutical Historical Data

The historical data trend for Collegium Pharmaceutical can be seen below:

2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 94.83 95.94 97.69 97.30 96.31 95.67 83.13 83.27 88.66 89.56
FRA:354
78GF Score
Collegium Pharmaceutical Inc FRA:354
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Collegium Pharmaceutical Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 89.56% mean?
Collegium Pharmaceutical (FRA:354) has a Institutional Ownership of 89.56% as of Aug. 06, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Collegium Pharmaceutical and its competitors.
Is Collegium Pharmaceutical's Institutional Ownership too high?
Collegium Pharmaceutical's current Institutional Ownership is 89.56%. Overall, Collegium Pharmaceutical has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Collegium Pharmaceutical's Institutional Ownership compare to ETON and ALVO?
Collegium Pharmaceutical's Institutional Ownership of 89.56% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Collegium Pharmaceutical and its competitors. Collegium Pharmaceutical's current Institutional Ownership is 89.56%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Collegium Pharmaceutical stock overvalued right now?
Collegium Pharmaceutical (FRA:354) has a current Institutional Ownership of 89.56%. The stock's GF Value™ is €36.94, compared to a current price of €30.60 — trading 17.2% below its estimated fair value. The current Institutional Ownership is 89.56%. Collegium Pharmaceutical's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Collegium Pharmaceutical (FRA:354), the current Institutional Ownership is 89.56% as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Collegium Pharmaceutical (FRA:354) Overvalued in 2026?

Based on GuruFocus' analysis, Collegium Pharmaceutical stock appears to be undervalued. The current stock price of €30.60 is trading 17.2% below its estimated GF Value™ of €36.94.

Key valuation signals for FRA:354:

  • Institutional Ownership: 89.56%
  • GF Value™: €36.94 vs. price of €30.60 (17.2% below fair value)
  • GF Score™: 78/100 with 3 warning signs

No single metric tells the full story. See the FRA:354 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Collegium Pharmaceutical Business Description

Other Exchanges COLL:USA354:Germany
Address 100 Technology Center Drive, Stoughton, MA, USA, 02072
Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.
78GF Score

Get the complete analysis for FRA:354

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€30.60
Price
€36.94
GF Value